Our Mass Torts Section has been litigating shoulder pain pump cases for the last two years. These cases involve an extreme injury to the shoulder cartilage after local anesthetics are infused into the joint space for 48 – 72 hours after surgery. Evidence suggests that this will kill all the cartilage in the patient’s shoulder. The FDA has reviewed adverse event reports related to chondrolysis in the shoulder and finally issued an order requiring a change in warning labels.
We are glad to see the FDA action. We believe it is the very action that some brave orthopedic surgeons have been calling for quite some time. The action by the FDA will require the manufacturers of the anesthetics to change their product labels to warn healthcare professionals that the anesthetics can damage cartilage. The FDA will also require the manufacturers of the pain pumps that may be used to infuse the local anesthetic to have similar warnings for their products. If you need additional information on the pain pumps litigation, contact Frank Woodson at 800-898-2034 or Frank.Woodson@beasleyallen.com.
Source: FDA Website
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.